Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumors

BMC Cancer

Table 2 Peritumoral pathological findings The number of the mice in each experimental group is specified by n. CGA is the control group and TG1-A, TG2-A and TG3-A are the experimental subgroups of the group treated with 77 C/cm³at 1, 2 and 4 days after DEC treatment, respectively. Mc Nemar Test shows statistically significant differences in peritumoral findings at 1, 2 and 4 days.

Alterations found	Experimental Groups	Number of mice (% of the total) in different degrees of alteration^b
		-	+	++	+++
Lymphoplasmocytic infiltrate: Lymphocytes (L) and plasmatic cells (CP)	CGA (n = 6)	0 (0.0)	0 (0.0)	6 (100.0)	0 (0.0)
	TGA-1 day (n = 6)	0 (0.0)	0 (0.0)	6 (100.0)	0 (0.0)
	TGA-2 days (n = 6)	0 (0.0)	0 (0.0)	6 (100.0)	0 (0.0)
	TGA-4 days (n = 6)	0 (0.0)	0 (0.0)	6 (100.0)	0 (0.0)
Neutrophilic infiltrate (N)	CGA (n = 6)	6 (100.0)	0 (0.0)	0 (0.0)	0 (0.0)
	TGA-1 day(n = 6)	0 (0.0)	0 (0.0)	0 (0.0)	6 (100.0)^a
	TGA-2 days (n = 6)	0 (0.0)	0 (0.0)	0 (0.0)	6 (100.0)^a
	TGA-4 days (n = 6)	0 (0.0)	0 (0.0)	0 (0.0)	6 (100.0)^a
Monocytic infiltrate (M)	CGA (n = 6)	6 (100.0)	0 (0.0)	0 (0.0)	0 (0.0)
	TGA-1 day (n = 6)	0 (0.0)	6 (100.0)^a	0 (0.0)	0 (0.0)
	TGA-2 days (n = 6)	0 (0.0)	0 (0.0)	6 (100.0)^a	0 (0.0)
	TGA-4 days (n = 6)	0 (0.0)	0 (0.0)	6 (100.0)^a	0 (0.0)
Vascular congestion (CV)	CGA (n = 6)	6 (100.0)	0 (0.0)	0 (0.0)	0 (0.0)
	TGA-1 day (n = 6)	0 (0.0)	0 (0.0)	0 (0.0)	6 (100.0)^a
	TGA-2 days (n = 6)	0 (0.0)	0 (0.0)	0 (0.0)	6 (100.0)^a
	TGA-4 days (n = 6)	0 (0.0)	0 (0.0)	0 (0.0)	6 (100.0)^a

^a P = 0.008.
^b Note: The signs " -, +, ++ and +++ ", represent: none, slight, moderate and severe intensity grades of alterations found, respectively.

ISSN: 1471-2407